Jefferies Raises Target on Body Central (BODY) Ahead of Q4 Results

Jefferies raised its price target on Buy-rated Body Central Corp. (NASDAQ: BODY) from $31 to $35 ahead of Q4 results, due tonight after the close.

The firm comments, "4Q Results are mostly known due to the January pre-announcement, and we think BODY has continued into a strong 1Q and remain very optimistic on the name. Management was very positive during the recent ICR conference, giving us further confidence in both near term performance and longer term prospects at this pure-play growth story."

For an analyst ratings summary and ratings history on Body Central Corp. click here. For more ratings news on Body Central Corp. click here.

Shares of Body Central Corp. closed at $28.74 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Cummins (CMI) PT Lowered to $675 at Jefferies
• Beike (BEKE) PT Raised to $23 at Morgan Stanley
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics